Advertisement
J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1194/jlr.M600529-JLR200 on January 24, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M600529-JLR200v1
48/4/944    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meaney, S.
Right arrow Articles by Björkhem, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meaney, S.
Right arrow Articles by Björkhem, I.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 48, 944-951, April 2007
Copyright © 2007 by American Society for Biochemistry and Molecular Biology


Patient-Oriented Research

Novel route for elimination of brain oxysterols across the blood-brain barrier: conversion into 7{alpha}-hydroxy-3-oxo-4-cholestenoic acid

Steve Meaney1,*, Maura Heverin1,*, Ute Panzenboeck{dagger}, Lena Ekström§, Magnus Axelsson**, Ulla Andersson*, Ulf Diczfalusy*, Irina Pikuleva{dagger}{dagger}, John Wahren§§, Wolfgang Sattler*** and Ingemar Björkhem2,*

* Division of Clinical Chemistry, Karolinska University Hospital, Huddinge, Sweden
§ Division of Clinical Pharmacology, Karolinska University Hospital, Huddinge, Sweden
** Division of Clinical Chemistry, Karolinska University Hospital, Solna, Sweden
§§ Division of Surgical Sciences, Karolinska University Hospital, Solna, Sweden
{dagger}{dagger} Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX
{dagger} Institute of Pathophysiology, Medical University Graz, Graz, Austria
*** Institute of Molecular Biology and Biochemistry, Center of Molecular Medicine, Medical University Graz, Graz, Austria

Published, JLR Papers in Press, January 24, 2007.

1 S. Meaney and M. Heverin contributed equally to this work.

2 To whom correspondence should be addressed. e-mail: ingemar.bjorkhem{at}karolinska.se


ABSTRACT

Recently, we demonstrated a net blood-to-brain passage of the oxysterol 27-hydroxycholesterol corresponding to 4–5 mg/day. As the steady-state levels of this sterol are only 1–2 µg/g brain tissue, we hypothesized that it is metabolized and subsequently eliminated from the brain. To explore this concept, we first measured the capacity of in vitro systems representing the major cell populations found in the brain to metabolize 27-hydroxycholesterol. We show here that 27-hydroxycholesterol is metabolized into the known C27 steroidal acid 7{alpha}-hydroxy-3-oxo-4-cholestenoic acid by neuronal cell models only. Using an in vitro model of the blood-brain barrier, we demonstrate that 7{alpha}-hydroxy-3-oxo-4-cholestenoic acid is efficiently transferred across monolayers of primary brain microvascular endothelial cells. Finally, we measured the concentration of 7{alpha}-hydroxy-3-oxo-4-cholestenoic acid in plasma from the internal jugular vein and brachial artery of healthy volunteers. Calculation of the arteriovenous concentration difference revealed a significant in vivo flux of this steroid from the brain into the circulation in human. Together, these studies identify a novel metabolic route for the elimination of 27-hydroxylated sterols from the brain. Given the emerging connections between cholesterol and neurodegeneration, this pathway may be of importance for the development of these conditions.

Supplementary key words brain cholesterol homeostasis • 27-hydroxycholesterol • CYP7B1 • CYP27


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
R. Schule, T. Siddique, H.-X. Deng, Y. Yang, S. Donkervoort, M. Hansson, R. E. Madrid, N. Siddique, L. Schols, and I. Bjorkhem
Marked accumulation of 27-hydroxycholesterol in SPG5 patients with hereditary spastic paresis
J. Lipid Res., April 1, 2010; 51(4): 819 - 823.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Ogundare, S. Theofilopoulos, A. Lockhart, L. J. Hall, E. Arenas, J. Sjovall, A. G. Brenton, Y. Wang, and W. J. Griffiths
Cerebrospinal Fluid Steroidomics: Are Bioactive Bile Acids Present in Brain?
J. Biol. Chem., February 12, 2010; 285(7): 4666 - 4679.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement